Lawsuits against Bayer Healthcare over its dangerous anticoagulant Xarelto have not only been stacking up in the U.S., but suits are cropping up in Canada, as well. A class action lawsuit was filed in Calgary over the drug’s uncontrollable bleeding side-effects, and a similar claim is expected to be filed in Ontario. The Calgary suit alleges that Health Canada, the Canadian equivalent to the American FDA, received over 1,000 reports complaining of adverse side-effects linked to Xarelto.
Xarelto lawsuits in the U.S. have been organized and centralized under one judge in a multi-district litigation (MDL), not a class action, but there are some similarities. In an MDL, each lawsuit remains its own case—but is gathered together with cases of similar claims to expedite proceedings—whereas a class action groups cases together under one umbrella.